-

SHAREHOLDER ALERT: Robbins LLP Announces that ATI Physical Therapy, Inc. (ATIP) f/k/a Fortress Value Acquisition Corp. II (FVAC) is Being Sued for Misleading Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired ATI Physical Therapy, Inc. (NYSE: ATIP) securities between April 1, 2021 and July 23, 2021, and/or held FVAC Class A common stock as of May 24, 2021 and were eligible to vote at FVAC's June 15, 2021 special meeting. The complaint alleges violations of the Securities Exchange Act of 1934.

If you suffered a loss due to ATI Physical Therapy, Inc.'s misconduct, click here.

ATI Physical Therapy, Inc. (ATIP) Made Misleading Statements Regarding its Business, Operations, and Prospects

According to the complaint, Fortress Value Acquisition Corp. II was a special purpose acquisition company that went public in August 2020. ATI is an outpatient physical therapy company that owns and operates nearly 900 clinics across 25 states. On June 17, 2021, ATI became public via a business combination with FVAC ("business combination").

During the relevant period, the Company stated it was "focused on accelerating hiring to serve outsized demand," noting it was the "Employer of Choice for PT Clinicians" and touted its staffing strategy, claiming that it would achieve "significant labor savings through more productive staffing model."

On July 26, 2021, ATI reported its financial results for second quarter 2021, the period in which the business combination was complete. ATI reported that “the acceleration of attrition among [its] therapists in the second quarter and continuing into the third quarter, combined with the intensifying competition for clinicians in the labor market, prevented us from being able to meet the demand we have and increased our labor costs.” Though ATI was implementing certain remedial actions, the Company reduced its fiscal 2021 forecast due to the foregoing factors. On this news, the Company's share price fell $3.62, or 43%, to close at $4.72 per share on July 26, 2021, and declined an additional 19% the next trading session.

If you purchased shares of ATI Physical Therapy, Inc. (ATIP) securities between April 1, 2021 and July 23, 2021, and/or held FVAC Class A common stock as of May 24, 2021 and were eligible to vote at FVAC's June 15, 2021 special meeting, you have until October 15, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against ATI Physical Therapy, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:ATIP

Release Versions

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Alert: Robbins LLP Informs Investors of the Wise Group plc Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Wise Group plc (NASDAQ: WSE) securities between May 11, 2026 and July 23, 2026 (the "Class Period").The complaint alleges that Wise and certain of its senior executives violated the federal securities laws by making materially false and/or misleading statements regarding the Company's anti-money laundering compliance, a...

Shareholder Alert - Robbins LLP Informs Investors of the Capricor Therapeutics, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026 (the "Class Period").The lawsuit alleges that Capricor Therapeutics misled investors regarding the path to FDA approval for its lead product candidate Deramiocel, a cell therapy to address cardiac and skeletal muscle compli...

Shareholder Alert - Robbins LLP Informs Investors of the Bloom Energy Corporation Class Action Lawsuit 

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Bloom Energy Corporation (NYSE: BE) securities between February 27, 2025 and July 8, 2026 (the "Class Period").Bloom Energy designs, manufactures, sells, and installs solid oxide fuel cell systems for on-site power generation in the United States and internationally. Scandium is a rare earth metal used as a dopant to st...
Back to Newsroom